BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 31111470)

  • 1. Does the gene matter? Genotype-phenotype and genotype-outcome associations in congenital melanocytic naevi.
    Polubothu S; McGuire N; Al-Olabi L; Baird W; Bulstrode N; Chalker J; Josifova D; Lomas D; O'Hara J; Ong J; Rampling D; Stadnik P; Thomas A; Wedgeworth E; Sebire NJ; Kinsler VA
    Br J Dermatol; 2020 Feb; 182(2):434-443. PubMed ID: 31111470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRAF mutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi.
    Salgado CM; Basu D; Nikiforova M; Bauer BS; Johnson D; Rundell V; Grunwaldt LJ; Reyes-Múgica M
    Pediatr Dev Pathol; 2015; 18(1):1-9. PubMed ID: 25490715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The BRAF and NRAS mutation prevalence in dermoscopic subtypes of acquired naevi reveals constitutive mitogen-activated protein kinase pathway activation.
    Tan JM; Tom LN; Jagirdar K; Lambie D; Schaider H; Sturm RA; Soyer HP; Stark MS
    Br J Dermatol; 2018 Jan; 178(1):191-197. PubMed ID: 28714107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NRAS p.Q61R/K allele load is correlated to different phenotypes of congenital melanocytic naevi.
    Zhao X; Dai Y; Zhang L; Liu Y; Chen H; Yue X; Yu L
    Clin Exp Dermatol; 2022 Dec; 47(12):2201-2207. PubMed ID: 35962610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Final congenital melanocytic naevi colour is determined by normal skin colour and unaltered by superficial removal techniques: a longitudinal study.
    Polubothu S; Kinsler VA
    Br J Dermatol; 2020 Mar; 182(3):721-728. PubMed ID: 31120141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS.
    Kinsler VA; Thomas AC; Ishida M; Bulstrode NW; Loughlin S; Hing S; Chalker J; McKenzie K; Abu-Amero S; Slater O; Chanudet E; Palmer R; Morrogh D; Stanier P; Healy E; Sebire NJ; Moore GE
    J Invest Dermatol; 2013 Sep; 133(9):2229-36. PubMed ID: 23392294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Massively parallel sequencing analysis of benign melanocytic naevi.
    Lozada JR; Geyer FC; Selenica P; Brown D; Alemar B; Merghoub T; Berger MF; Busam KJ; Halpern AC; Weigelt B; Reis-Filho JS; Hollmann TJ
    Histopathology; 2019 Jul; 75(1):29-38. PubMed ID: 30791119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High BRAF mutation frequency does not characterize all melanocytic tumor types.
    Saldanha G; Purnell D; Fletcher A; Potter L; Gillies A; Pringle JH
    Int J Cancer; 2004 Sep; 111(5):705-10. PubMed ID: 15252839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of the BRAF gene in human congenital and dysplastic melanocytic naevi.
    Papp T; Schipper H; Kumar K; Schiffmann D; Zimmermann R
    Melanoma Res; 2005 Oct; 15(5):401-7. PubMed ID: 16179867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated non-coding promoter mutations are associated with malignant transformation of melanocytic naevi to melanoma.
    Colebatch AJ; Paver EC; Vergara IA; Thompson JF; Long GV; Wilmott JS; Scolyer RA
    Pathology; 2022 Aug; 54(5):533-540. PubMed ID: 35248370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel genetic alteration in congenital melanocytic nevus: MAP2K1 germline mutation with BRAF somatic mutation.
    Zou Y; Sun Y; Zeng X; Liu Y; Cen Q; Gu H; Lin X; Cai R; Chen H
    Hereditas; 2020 Aug; 157(1):35. PubMed ID: 32847629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The retrospective molecular analysis of large or giant congenital melanocytic nevi in a group of Polish children.
    Wertheim-Tysarowska K; Szczygielski O; Seliga K; Tysarowski A; Bal J; Michalak E; Rygiel AM; Sawicka E
    J Mother Child; 2021 Oct; 25(1):19-24. PubMed ID: 34643354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Abnormalities in Large to Giant Congenital Nevi: Beyond NRAS Mutations.
    Martins da Silva V; Martinez-Barrios E; Tell-Martí G; Dabad M; Carrera C; Aguilera P; Brualla D; Esteve-Codina A; Vicente A; Puig S; Puig-Butillé JA; Malvehy J
    J Invest Dermatol; 2019 Apr; 139(4):900-908. PubMed ID: 30359577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of BRAF V600E gene mutation with proliferative activity and histopathological characteristics of congenital melanocytic nevi in children.
    Chen J; Zhang G; Liu X; Tu P
    An Bras Dermatol; 2023; 98(4):498-505. PubMed ID: 37156689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of cell-free circulating BRAF
    Calbet-Llopart N; Potrony M; Tell-Martí G; Carrera C; Barreiro A; Aguilera P; Podlipnik S; Puig S; Malvehy J; Puig-Butillé JA
    Br J Dermatol; 2020 Feb; 182(2):382-389. PubMed ID: 31102256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi.
    Charbel C; Fontaine RH; Malouf GG; Picard A; Kadlub N; El-Murr N; How-Kit A; Su X; Coulomb-L'Hermine A; Tost J; Mourah S; Aractingi S; Guégan S
    J Invest Dermatol; 2014 Apr; 134(4):1067-1074. PubMed ID: 24129063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing.
    Edlundh-Rose E; Egyházi S; Omholt K; Månsson-Brahme E; Platz A; Hansson J; Lundeberg J
    Melanoma Res; 2006 Dec; 16(6):471-8. PubMed ID: 17119447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanocortin-1 receptor (MC1R) genotypes do not correlate with size in two cohorts of medium-to-giant congenital melanocytic nevi.
    Calbet-Llopart N; Pascini-Garrigos M; Tell-Martí G; Potrony M; Martins da Silva V; Barreiro A; Puig S; Captier G; James I; Degardin N; Carrera C; Malvehy J; Etchevers HC; Puig-Butillé JA
    Pigment Cell Melanoma Res; 2020 Sep; 33(5):685-694. PubMed ID: 32323445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of oncogenic BRAF mutations and p16 expression on the growth rate of early melanomas and naevi in vivo.
    Tschandl P; Berghoff AS; Preusser M; Pammer J; Pehamberger H; Kittler H
    Br J Dermatol; 2016 Feb; 174(2):364-70. PubMed ID: 26613644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRAF somatic mutations in malignant melanoma and melanocytic naevi.
    Thomas NE
    Melanoma Res; 2006 Apr; 16(2):97-103. PubMed ID: 16567964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.